ZYME is currently covered by 8 analysts with average potential upside of $12.52 (66.3%) backed by 57 price targets and 68 ratings. Documented since 23-May-2017. Analyst's average stock valuation to be materialised ratio is 51.32% with an average time for price targets to be met of 110.44 days.
Most recent stock forecast was given by ROBERT BURNS from HCWAINWRIGHT on 21-Mar-2023.
Highest price target for ZYME is 35, Lowest price target is 5, average price target is 20.
Currently, out of the existing stock ratings of ZYME - 16 which are a Buy (53.33%), 13 which are a Hold (43.33%), 1 which are a Sell (3.33%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
8
$-0.2 (-2.44%)
8
4 days ago
5/12 (41.67%)
$12.12 (72.16%)
49
Buy
12
$3.8 (46.34%)
45
4 days ago
2/7 (28.57%)
$19.41 (123.59%)
373
Hold
9
$0.8 (9.76%)
38
3 months 3 days ago
5/5 (100%)
$0.68 (2.44%)
15
Buy
11
$2.8 (34.15%)
8
3 months 5 days ago
1/3 (33.33%)
$4.29 (36.45%)
5
Buy
8
$-0.2 (-2.44%)
5 months 4 days ago
2/8 (25%)
$8.34 (29.29%)
32
What is ZYME(Zymeworks Inc) average time for price targets to be met?
Which analyst has the current highest performing score on ZYME(Zymeworks Inc) with a proven track record?
